Replies to post #54226 on MMRGlobal, Inc. (fka MMRF)

[EZ2]

On the biotech side, MMR received two additional patents for our anti-CD20 antibodies and B-Cell vaccine in Mexico. We also received a patent in Mexico for our Personal Health Record health IT service offerings. As a result of the Company’s intellectual property portfolio, we have already received more than one million dollars in license fees and signed numerous biotech and health IT licensing agreements which already call for payments in excess of 40 million dollars over the next four years.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82976421

(read more / post less ---- why God gave us two ears and only one mouth) <vbg> <<<<< TALKING about MYSELF here!!

[tiffer]

On the biotech side, MMR received two additional patents for our anti-CD20 antibodies and B-Cell vaccine in Mexico. We also received a patent in Mexico for our Personal Health Record health IT service offerings. As a result of the Company’s intellectual property portfolio, we have already received more than one million dollars in license fees and signed numerous biotech and health IT licensing agreements which already call for payments in excess of 40 million dollars over the next four years.END. Health IT and BIO in the same sentence in sticky above "2012 lookin back". Percentage of each I have no idea but I cannot help but think of 10 million from Celgene and 30 million from Omidi Bros which if that is the case makes it just another fluff PR. I am placing my main expectations on E-Mail Frequency as I prefer real versus unreal. Of course this is just my opinion. .Tif